Emerging Technologies for the Assessment of Gametes and Embryos: The "Omics"

It is the policy of BioSymposia, Inc. to ensure fair balance, independence, objectivity and scientific rigor in all its sponsored educational programs. Therefore all faculty participating in these programs are required to disclose to the audience any significant financial relationships related to the content of the presentation. Disclosure of the faculty's commercial relationships will be made known at the activity. Faculty are also expected to openly disclose any discussion of off-label and/or investigational uses of drugs or devices in their presentations.